← Back to Search

Protein Supplement

Pea Protein Supplement for Sarcopenia

N/A

Waitlist Available

Led By Stuart Phillips, Ph.D.

Research Sponsored by McMaster University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 7 days x 2

Awards & highlights

Study Summary

This trial will study the effects of different types of protein supplements on muscle protein synthesis in healthy older men.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 7 days x 2

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~7 days x 2

This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 days x 2 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Integrated Muscle Protein Synthesis

Secondary outcome measures

Anabolic Signalling Proteins

Trial Design

3Treatment groups

Experimental Treatment

Group I: Whey Protein SupplementExperimental Treatment1 Intervention

Supplements will be consumed twice daily (25g per serving x 2 servings/day)

Group II: Pea Protein SupplementExperimental Treatment1 Intervention

Supplements will be consumed twice daily (25g per serving x 2 servings/day)

Group III: Collagen Protein SupplementExperimental Treatment1 Intervention

Supplements will be consumed twice daily (25g per serving x 2 servings/day)

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Protein Supplementation

2019

N/A

~160

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

McMaster UniversityLead Sponsor

881 Previous Clinical Trials

2,597,841 Total Patients Enrolled

6 Trials studying Sarcopenia

164 Patients Enrolled for Sarcopenia

Stuart Phillips, Ph.D.Principal InvestigatorMcMaster University

7 Previous Clinical Trials

274 Total Patients Enrolled

1 Trials studying Sarcopenia

81 Patients Enrolled for Sarcopenia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current size of the cohort enrolled in this investigation?

"Affirmative. According to information on clinicaltrials.gov, this scientific experiment is presently enrolling participants and was initially posted on December 1st 2019. Subsequently, the trial has been actively seeking out 45 volunteers over a single site."

Answered by AI

Will those aged 75 and over be considered for participation in this experiment?

"This clinical trial is seeking participants who are elderly, ranging between 65 and 80 years of age."

Answered by AI

Is this experiment currently looking to enlist participants?

"Affirmative. According to the clinicaltrials.gov information, this medical experiment is still taking participants since it was initially posted on December 1 2019 and updated most recently in November of 2022. 45 patients are being recruited from one site."

Answered by AI

For whom is this medical research most appropriate?

"For one to be eligible for this research, they must have sarcopenia and fall within the age bracket of 65-80. This study is seeking out approximately 45 participants in total."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Protein Quality to Support Increased Muscle Protein Synthesis

Stuart Phillips 2019. "Protein Quality to Support Increased Muscle Protein Synthesis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04026607.